Breakthru Medicine
PrivateLast Round
Series A
Jan 29, 2026
Total Funding Raised
$60M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Breakthru Medicine is a biotechnology company developing oncology therapies for solid cancers using antibody-drug conjugates, small molecules, and molecular glues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breakthru Medicine Comparables
Compare Breakthru Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fortitude Biomedicines | 87% | |
| Nested Therapeutics | 85% | |
| Kivu Biosciences | 83% |
Breakthru Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 29, 2026 |
Breakthru Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eshelman Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 305% MoM, reaching 2.4K.
- Jan 29, 2026
Company emerges from stealth with Series A financing.
Breakthru Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Breakthru Medicine's valuation, stock price, and market status.
Is Breakthru Medicine a public or private company?
Breakthru Medicine is a private company.
What is the current stock price of Breakthru Medicine?
Breakthru Medicine is a private company, so its shares have no public market price. Caplight tracks Breakthru Medicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Breakthru Medicine worth (valuation)?
Valuation information for Breakthru Medicine is not publicly available.
Can I buy Breakthru Medicine stock?
Breakthru Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Breakthru Medicine's last funding round?
Breakthru Medicine's most recent funding round was Series A on January 29, 2026.
Who are the main investors in Breakthru Medicine?
Key investors in Breakthru Medicine include Eshelman Ventures.
Will Breakthru Medicine IPO soon?
No public IPO plans have been announced for Breakthru Medicine.
How can I track Breakthru Medicine secondary market activity?
Caplight tracks bids, offers, and trades in Breakthru Medicine's shares on secondary markets.